Skip to main content
PMC home page
Gut logoLink to Gut
. 1993 Dec;34(12):1722–1725. doi: 10.1136/gut.34.12.1722

Comparison of two sialosyl-Tn binding monoclonal antibodies (MLS102 and B72.3) in detecting pancreatic cancer.

C K Ching 1, S W Holmes 1, G K Holmes 1, R G Long 1
PMCID: PMC1374471  PMID: 8282261

Abstract

An immunohistochemical study has been carried out to compare and contrast the cellular distribution of two different sialosyl-Tn antigen binding monoclonal antibodies, MLS102 and B72.3, in the pancreas. MLS102 but not B72.3 monoclonal antibody binding increases with the content of the sialosyl-Tn epitopes. It was found that all 13 pancreatic cancer specimens bound both MLS102 and B72.3 monoclonal antibodies. Their cellular distribution in the cancer was virtually identical. Fifteen of 20 (75%) patients with chronic pancreatitis and five of 10 (50%) normal subjects were B72.3 positive, but MLS102 was completely negative in the latter group. Both monoclonal antibodies bound fetal pancreas diffusely. Thus, when pancreatic ductal cells have undergone malignant transformation, like the fetal pancreas, they express cell surface and secreted glycoconjugates with increased sialosyl-Tn epitopes suggesting enhanced 2-6 sialosyltransferase activity. This study shows that MLS102 is an extremely sensitive and specific tumour marker in the pancreas and that it is better than B72.3 in distinguishing pancreatic cancer from normal and chronic pancreatitis.

Full text

PDF
1723

Images in this article

1723Figure 1
on p.1723
1723Figure 2
on p.1723
1724Figure 3
on p.1724
1724Figure 4
on p.1724

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Colcher D., Hand P. H., Nuti M., Schlom J. A spectrum of monoclonal antibodies reactive with human mammary tumor cells. Proc Natl Acad Sci U S A. 1981 May;78(5):3199–3203. doi: 10.1073/pnas.78.5.3199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Feizi T. Demonstration by monoclonal antibodies that carbohydrate structures of glycoproteins and glycolipids are onco-developmental antigens. Nature. 1985 Mar 7;314(6006):53–57. doi: 10.1038/314053a0. [DOI] [PubMed] [Google Scholar]
  3. Frebourg T., Bercoff E., Manchon N., Senant J., Basuyau J. P., Breton P., Janvresse A., Brunelle P., Bourreille J. The evaluation of CA 19-9 antigen level in the early detection of pancreatic cancer. A prospective study of 866 patients. Cancer. 1988 Dec 1;62(11):2287–2290. doi: 10.1002/1097-0142(19881201)62:11<2287::aid-cncr2820621103>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  4. Hakomori S. Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv Cancer Res. 1989;52:257–331. doi: 10.1016/s0065-230x(08)60215-8. [DOI] [PubMed] [Google Scholar]
  5. Ichihara T., Sakamoto J., Nakao A., Furukawa K., Watanabe T., Suzuki N., Horisawa M., Nagura H., Lloyd K. O., Takagi H. Expression of blood group-related antigens in normal and malignant pancreatic tissue correlated with genotype of the patient defined by saliva glycoprotein. Cancer. 1993 Jan 1;71(1):71–81. doi: 10.1002/1097-0142(19930101)71:1<71::aid-cncr2820710113>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  6. Itzkowitz S. H., Bloom E. J., Kokal W. A., Modin G., Hakomori S., Kim Y. S. Sialosyl-Tn. A novel mucin antigen associated with prognosis in colorectal cancer patients. Cancer. 1990 Nov 1;66(9):1960–1966. doi: 10.1002/1097-0142(19901101)66:9<1960::aid-cncr2820660919>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  7. Itzkowitz S., Kjeldsen T., Friera A., Hakomori S., Yang U. S., Kim Y. S. Expression of Tn, sialosyl Tn, and T antigens in human pancreas. Gastroenterology. 1991 Jun;100(6):1691–1700. doi: 10.1016/0016-5085(91)90671-7. [DOI] [PubMed] [Google Scholar]
  8. Kjeldsen T., Clausen H., Hirohashi S., Ogawa T., Iijima H., Hakomori S. Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2----6 alpha-N-acetylgalactosaminyl (sialosyl-Tn) epitope. Cancer Res. 1988 Apr 15;48(8):2214–2220. [PubMed] [Google Scholar]
  9. Klug T. L., Sattler M. A., Colcher D., Schlom J. Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 72) on a novel pancarcinoma antigen (TAG-72). Int J Cancer. 1986 Nov 15;38(5):661–669. doi: 10.1002/ijc.2910380508. [DOI] [PubMed] [Google Scholar]
  10. Kurosaka A., Kitagawa H., Fukui S., Numata Y., Nakada H., Funakoshi I., Kawasaki T., Ogawa T., Iijima H., Yamashina I. A monoclonal antibody that recognizes a cluster of a disaccharide, NeuAc alpha(2----6)GalNAc, in mucin-type glycoproteins. J Biol Chem. 1988 Jun 25;263(18):8724–8726. [PubMed] [Google Scholar]
  11. Motoo Y., Kawakami H., Watanabe H., Satomura Y., Ohta H., Okai T., Makino H., Toya D., Sawabu N. Serum sialyl-Tn antigen levels in patients with digestive cancers. Oncology. 1991;48(4):321–326. doi: 10.1159/000226951. [DOI] [PubMed] [Google Scholar]
  12. Schuessler M. H., Pintado S., Welt S., Real F. X., Xu M., Melamed M. R., Lloyd K. O., Oettgen H. F. Blood group and blood-group-related antigens in normal pancreas and pancreas cancer: enhanced expression of precursor type 1, Tn and sialyl-Tn in pancreas cancer. Int J Cancer. 1991 Jan 21;47(2):180–187. doi: 10.1002/ijc.2910470204. [DOI] [PubMed] [Google Scholar]
  13. Sell S. Cancer-associated carbohydrates identified by monoclonal antibodies. Hum Pathol. 1990 Oct;21(10):1003–1019. doi: 10.1016/0046-8177(90)90250-9. [DOI] [PubMed] [Google Scholar]
  14. Takada A., Ohmori K., Yoneda T., Tsuyuoka K., Hasegawa A., Kiso M., Kannagi R. Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium. Cancer Res. 1993 Jan 15;53(2):354–361. [PubMed] [Google Scholar]
  15. Takiyama Y., Tempero M. A., Takasaki H., Onda M., Tsuchiya R., Büchler M., Ness M., Colcher D., Schlom J., Pour P. M. Reactivity of CO17-1A and B72.3 in benign and malignant pancreatic diseases. Hum Pathol. 1989 Sep;20(9):832–838. doi: 10.1016/0046-8177(89)90093-2. [DOI] [PubMed] [Google Scholar]
  16. Yogeeswaran G., Salk P. L. Metastatic potential is positively correlated with cell surface sialylation of cultured murine tumor cell lines. Science. 1981 Jun 26;212(4502):1514–1516. doi: 10.1126/science.7233237. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES